Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

InCight, a division of CadentInCight, a division of Cadent
VS
Torrent Pharmaceuticals LtdTorrent Pharmaceuticals Ltd
InCight, a division of Cadent

InCight, a division of Cadent

N/A

Last Update: 24/12/2025

View Profile
Between 750 and 799
https://incight.info/
753/1000Fair

We translate your evidence into impactful and engaging insight-driven Medical Communication plans. Our capabilities include scientific communication platforms, best-in-class peer-reviewed publications, award-winning educational videos, and more.

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:None
Subsidiaries:14
12-month incidents
0
Known data breaches
0
Attack type number
0
Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals Ltd, Ahmedabad, 380015, IN

Last Update: 13/09/2026

View Profile
Between 750 and 799
http://www.torrentpharma.com
794/1000Fair

Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:11,552
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
InCight, a division of Cadent

InCight, a division of Cadent

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals Ltd

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for InCight, a division of Cadent in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Torrent Pharmaceuticals Ltd in 2026.

Incidents

Incident History - InCight, a division of Cadent (X = Date, Y = Severity)

InCight, a division of Cadent cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Torrent Pharmaceuticals Ltd (X = Date, Y = Severity)

Torrent Pharmaceuticals Ltd cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
InCight, a division of Cadent

InCight, a division of Cadent

Incidents
No explicit notable incidents reported.
Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals Ltd

Incidents
No explicit notable incidents reported.

FAQ

Between InCight, a division of Cadent company and Torrent Pharmaceuticals Ltd company, which one has the best AI Cybersecurity Score ?
Between InCight, a division of Cadent company and Torrent Pharmaceuticals Ltd company, which one has experienced more cyber incidents in the past ?
Between InCight, a division of Cadent company and Torrent Pharmaceuticals Ltd company, which one has experienced more cyber incidents this year ?
Between InCight, a division of Cadent company and Torrent Pharmaceuticals Ltd company, which one has experienced at least one ransomware attack ?
Between InCight, a division of Cadent company and Torrent Pharmaceuticals Ltd company, which one has experienced at least one data breach ?
Between InCight, a division of Cadent company and Torrent Pharmaceuticals Ltd company, which one has experienced at least one targeted cyberattack ?
Between InCight, a division of Cadent company and Torrent Pharmaceuticals Ltd company, which one has experienced at least one vulnerability ?
Between InCight, a division of Cadent company and Torrent Pharmaceuticals Ltd company, which one holds the most compliance certifications ?
Between InCight, a division of Cadent company and Torrent Pharmaceuticals Ltd company, which one holds the fewest compliance certifications ?
Between InCight, a division of Cadent company and Torrent Pharmaceuticals Ltd company, which one has the most subsidiaries ?
Between InCight, a division of Cadent company and Torrent Pharmaceuticals Ltd company, which one has the largest number of employees ?
Between InCight, a division of Cadent and Torrent Pharmaceuticals Ltd, which company holds both SOC 2 Type 1 certifications ?
Between InCight, a division of Cadent and Torrent Pharmaceuticals Ltd, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - InCight, a division of Cadent or Torrent Pharmaceuticals Ltd ?
Which company is PCI DSS compliant - InCight, a division of Cadent or Torrent Pharmaceuticals Ltd ?
Between InCight, a division of Cadent and Torrent Pharmaceuticals Ltd, which company complies with HIPAA regulations for healthcare data ?
Between InCight, a division of Cadent and Torrent Pharmaceuticals Ltd, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-88964
SUMMARY

An integer underflow in OpenVPN version 2.7_alpha3 through 2.7.7 on Windows and Android allows remote authenticated servers to cause a denial of service or memory disclosure via crafted domain search options

PUBLISHED
Date2026-10-13
UPDATED
Date2026-10-13
RISK INFORMATION (Score: )
CVSS4
Base Score: 7.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
NA
EXPLOITABILITY
NA
CVE-2026-53564
SUMMARY

Vulnerability in Citrix UniconOS leading to Arbitrary file read and write This issue affects UniconOS: before 2607.2 CR and before 2603 LTSR CU2.

PUBLISHED
Date2026-10-13
UPDATED
Date2026-10-13
RISK INFORMATION (Score: )
CVSS4
Base Score: 5.1
Complexity: LOW
CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:P/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
NA
EXPLOITABILITY
NA
CVE-2026-53563
SUMMARY

Vulnerability in Citrix UniconOS leading to Persistent Command Execution This issue affects UniconOS: before 2607.2 CR and before 2603 LTSR CU2.

PUBLISHED
Date2026-10-13
UPDATED
Date2026-10-13
RISK INFORMATION (Score: )
CVSS4
Base Score: 6.9
Complexity: LOW
CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:N/VC:H/VI:L/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
NA
EXPLOITABILITY
NA
CVE-2026-15468
SUMMARY

Authorization bypass through User-Controlled key vulnerability in HYPR Passwordless on Windows allows Privilege Escalation. This issue affects HYPR Passwordless: before 11.3.3.

PUBLISHED
Date2026-10-13
UPDATED
Date2026-10-13
RISK INFORMATION (Score: )
CVSS4
Base Score: 6.9
Complexity: LOW
CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:N/VC:H/VI:L/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
NA
EXPLOITABILITY
NA
CVE-2026-105390
SUMMARY

Improper synchronization in the OpenVPN ovpn-dco-win for Windows versions 0.6.5 through 1.3.5 and 2.4.0 through 2.8.7 allows local attackers to trigger a deadlock via a crafted write to the ovpn-dco device, causing the host to become unresponsive.

PUBLISHED
Date2026-10-13
UPDATED
Date2026-10-13
RISK INFORMATION (Score: )
CVSS4
Base Score: 6.9
Complexity: LOW
CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
NA
EXPLOITABILITY
NA